Manus Aktteva
We are only a phone call away, Call us on: +91 79 65123395
+91 79 26463395
Home
About Us Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, API, Intermediate, Nutraceuticals, Intermediates, Speciality chemicals, Advance level intermediatesEventsNewsEnquiryContact UsResources
Manus Aktteva offers Imatinib Mesylate, 220127-57-1, from a WHO GMP plant with the Drug Master File, Open Part DMF and DMF in CTD Format also can be made available on request, Imatinib Mesylate Intermediates also can be made available
Products A to Z
       
Search The Site
Please enter all or part of your keyword to retrive data
Search by: Chemical Name
  CAS#
  Molecular Formula
Quick Help
Services
Queries
Tel1: +91 79 65123395
Tel2: +91 79 26463395
Email: click here
Twitter  Facebook
Imatinib Mesylate
Imatinib Mesylate
Imatinib is a drug used to treat certain types of cancer. It is currently marketed as its mesylate salt, imatinib mesylate. It is used in treating chronic myelogenous leukemia, gastrointestinal stromal tumors and a number of other malignancies. It is the first member of a new class of agents that act by inhibiting particular tyrosine kinase enzymes, instead of non-specifically inhibiting rapidly dividing cells.
Product Reference ID: MA-MK-1014-D
Imatinib Mesylate, 220127-57-1
Chemical Name: 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate
Description
CAS number 220127-57-1
Synonym 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate
Molecular Formula C29H31N7O•CH4SO3
Molecular Weight 589.7
Specifications Available on request
Packing Technical Package available
Application For treating chronic myelogenous leukemia
Material Safety Data Sheet
Available on request
Availability For your requirements of evaluation, Pilots and Commercial procurement
Drug Master File Open part DMF available, DMF in CTD Format can be made available
Back to Previous Page Click here to Inquire
Are you looking for Imatinib Mesylate Intermediates ? Please click here to browse through the list of Imatinib Mesylate Intermediates available with us.
Advertisement
NOTE: 
  • Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
       Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
  • Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS: 
  • => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
        => Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
© 2018 MANUS AKTTEVA  All rights reserved..
Payment Procedure